Better Therapeutics, Inc.

Better Therapeutics, Inc. went public through a merger with Mountain Crest Acquisition Corp., which traded under the ticker MCAD and was sponsored by Mountain Crest Capital LLC. The SPAC completed its IPO in 2021 and targeted the healthcare sector, ultimately combining with Better Therapeutics, a prescription digital therapeutics company focused on cardiometabolic disease. The 8-K filed on October 27, 2021, under accession number 0001104659-21-130534, represents a current report associated with the de-SPAC transaction and its related disclosures. Better Therapeutics develops software-based prescription therapies designed to address conditions such as type 2 diabetes. Sign up for SpacDesk to access the full filing history, deal timeline, and sponsor data for MCAD and hundreds of other SPACs.